scispace - formally typeset
H

Hatice Hasturk

Researcher at The Forsyth Institute

Publications -  127
Citations -  8384

Hatice Hasturk is an academic researcher from The Forsyth Institute. The author has contributed to research in topics: Periodontitis & Inflammation. The author has an hindex of 42, co-authored 114 publications receiving 6763 citations. Previous affiliations of Hatice Hasturk include Boston University.

Papers
More filters
Journal ArticleDOI

The use of light/chemically hardened polymethylmethacrylate, polyhydroxyethylmethacrylate, and calcium hydroxide graft material in combination with polyanhydride around implants in minipigs: part I: immediate stability and function.

TL;DR: The newly formulated chemically hardened graft material PPCH-PA was useful in immediate implant placement after tooth extraction and resulted in greater stability and a well-organized implant-bone interface with immediate loading, especially in those areas where cancellous bone was present.
Journal ArticleDOI

Periodontal inflammation and distinct inflammatory profiles in saliva and gingival crevicular fluid compared with serum and joints in rheumatoid arthritis patients

TL;DR: In this article, the association of periodontitis and Porphyromonas gingivalis (Pg) with rheumatoid arthritis (RA) is incompletely understood, and the authors evaluated periodontal status, oral, serum and joint inflammatory profiles, and Pg biomarkers in RA patients.
Journal ArticleDOI

Alternative Splicing Generates a Diacylglycerol Kinase α Transcript That Acts as a Dominant-Negative Modulator of Superoxide Production in Localized Aggressive Periodontitis

TL;DR: DGKαΔ10 can act as a dominant-negative transcript that can modulate superoxide production and provides an example of genetic regulation of the inflammatory response that may be relevant to human inflammatory diseases such as LAgP.
Patent

Delivery of h2 antagonists

TL;DR: In this article, the authors provide improved systems and methods for the local delivery of H2 antagonists, such as topical administration of an effective amount of a H2 antagonist encapsulated in liposomes.
Journal ArticleDOI

Annual alveolar bone loss in subjects with cardiovascular disease adjusting for associated systemic diseases and risk factors: a retrospective study

TL;DR: Subjects who have reported CVD had higher rate of annual bone loss compared to subjects who did not have any CVD, indicating that targeting high-risk individuals for risk assessment is fundamental to provide the best healthcare possible to those who are the most in need.